BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/21/2021 8:24:09 AM | Browse: 859 | Download: 2580
Publication Name World Journal of Clinical Cases
Manuscript ID 64585
Country China
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Infectious Diseases
Manuscript Type Case Control Study
Article Title Soluble programmed death-1 is predictive of HBsAg loss in chronic hepatitis B patients after antiviral treatment
Manuscript Source Unsolicited Manuscript
All Author List Ning Tan, Hao Luo, Qian Kang, Jia-Li Pan, Ran Cheng, Hong-Li Xi, Hong-Yu Chen, Yi-Fan Han, Yu-Qing Yang and Xiao-Yuan Xu
ORCID
Author(s) ORCID Number
Ning Tan http://orcid.org/0000-0001-9917-2192
Hao Luo http://orcid.org/0000-0002-2067-7217
Qian Kang http://orcid.org/0000-0001-5825-1660
Jia-Li Pan http://orcid.org/0000-0002-3448-7430
Ran Cheng http://orcid.org/0000-0001-6975-3498
Hong-Li Xi http://orcid.org/0000-0003-0389-7602
Hong-Yu Chen http://orcid.org/0000-0003-1382-8029
Yi-Fan Han http://orcid.org/0000-0002-5432-089X
Yu-Qing Yang http://orcid.org/0000-0002-0594-7047
Xiao-Yuan Xu http://orcid.org/0000-0002-1759-4330
Funding Agency and Grant Number
Funding Agency Grant Number
the 13th Five-Year Plan of Ministry of Science and Technology of the People’s Republic of China 2017ZX10302201-004-009
the 13th Five-Year Plan of Ministry of Science and Technology of the People’s Republic of China 2017ZX10203202-003
Beijing Municipal Science and Technology Commission of Major Projects D161100002716002
Beijing Municipal Science and Technology Commission of Major Projects D161100002716003
Corresponding Author Xiao-Yuan Xu, MD, Chief Physician, Professor, Department of Infectious Diseases, Peking University First Hospital, No.8 Xishiku Street, Beijing 100034, China. xiaoyuanxu6@163.com
Key Words Programmed cell death 1 protein; Hepatitis B surface antigen; Chronic hepatitis B; Antiviral; Nucleos(t)ide analogs; Hepatitis B e antigen
Core Tip This study analyzed the data and samples from patients with chronic hepatitis B who underwent antiviral treatment and were followed up for 12 years to investigate the factors associated with hepatitis B surface antigen (HBsAg) loss and explore the impact of soluble programmed death-1 (sPD-1) levels. The sPD-1 Levels were significantly different between patients with and without HBsAg loss during antiviral treatment. The sPD-1 Levels at 6 mo can predict HBsAg loss after 12 years of antiviral treatment.
Publish Date 2021-07-21 08:24
Citation Tan N, Luo H, Kang Q, Pan JL, Cheng R, Xi HL, Chen HY, Han YF, yang YP, Xu XY. Soluble programmed death-1 is predictive of HBsAg loss in chronic hepatitis B patients after antiviral treatment . World J Clin Cases 2021; 9(21): 5812-5821
URL https://www.wjgnet.com/2307-8960/full/v9/i21/5812.htm
DOI https://dx.doi.org/10.12998/wjcc.v9.i21.5812
Full Article (PDF) WJCC-9-5812.pdf
Full Article (Word) WJCC-9-5812.docx